Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ravisekhar Gadepalli

Ravisekhar Gadepalli

All India Institute of Medical Sciences, India

Title: Role of protease-activated receptors (PARs) and G-proteins in thrombin induced monocyte/macrophage migration

Biography

Biography: Ravisekhar Gadepalli

Abstract

The recruitment of monocytes/macrophages to the sites of dysfunctional endothelium and transformation of these cells into foam cells by the uptake of oxidized lipoproteins in the sub endothelium are the major pathophysiological features of atherosclerosis. Since thrombin is produced at the sites of vascular injury and in order to understand its involvement in atherosclerosis, we tested its role in the modulation of THP-1 cell migration. Thrombin induced THP-1 cell migration in a dose dependent manner. Thrombin induced sequentially the tyrosine phosphorylation of Pyk2, Gab1 and p115 RhoGEF leading to Rac1 and RhoA-dependent Pak2 activation. Downstream to Pyk2, Gab1 formed a complex with p115 RhoGEF involving their PH domains. Furthermore, depletion of Pyk2, Gab1, p115 RhoGEF, Rac1, RhoA or Pak2 levels using their respective antisense oligos substantially attenuated thrombin-induced THP-1 cell cytoskeleton formation and migration. In addition, SCH79797, a selective PAR1 antagonist, inhibited thrombin-induced Pyk2, Gab1 and p115 RhoGEF tyrosine phosphorylation and Rac1-RhoA-depenedent Pak2 activation resulting in diminished THP-1 cell cytoskeleton formation and migration. Together, these observations reveal that thrombin induces THP-1 cell migration via PAR1-dependent Pyk2-mediated Gab1 and p115 RhoGEF interactions leading to Rac1-RhoA-Pak2 activation. Based on these findings, we envision a role for thrombin and its receptor PAR1 in atherosclerosis.